TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
Carter
Andrew J
AJ
Cardiovascular Research, Providence Heart and Vascular Institute, Providence St. Vincent's Medical Center, Portland, Oregon, USA. acarter@providence.org
D002453:Cell Cycle / Q000502:physiology*; D023903:Coronary Restenosis / Q000150:complications / Q000517:prevention & control*; D048909:Diabetes Complications; D016503:Drug Delivery Systems; D006801:Humans; D011494:Protein Kinases; D015607:Stents; D058570:TOR Serine-Threonine Kinases
D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases